Lilly Immergluck to Antibodies, Neutralizing
This is a "connection" page, showing publications Lilly Immergluck has written about Antibodies, Neutralizing.
Connection Strength
0.053
-
Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial. Clin Infect Dis. 2023 08 22; 77(4):560-564.
Score: 0.053